Overview

Losartan in Prevention of Radiation-Induced Heart Failure

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is being done to see if losartan affects the chances of developing radiation-induced heart failure in patients who are receiving radiation therapy as part of standard of care treatment for breast cancer. The interventions involved in this study are: - Losartan - Radiation Therapy (standard of care)
Phase:
Early Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Losartan